Noticias Vallon Pharmaceuticals - VLON

Nombre de la Acción	Símbolo de la Acción	Bolsa de Valores	Tipo de Valor
Vallon Pharmaceuticals Inc	VLON	NASDAQ	Acción Común

	Variación del Día (ptos.)	Variación del Día (%)	Último Precio	Hora
	0.00	0.00%	0.40	19:00:00

Precio de Apertura	Precio Mínimo	Precio Máximo	Precio de cierre	Precio Anterior
			0.40	0.40

Noticias Recientes

Fecha	Hora	Fuente	Noticia
01/4/2024	08:13	EDGAR2	Form 8-K - Current report
28/3/2024	15:45	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
28/3/2024	15:42	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
02/2/2024	15:25	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
02/2/2024	15:23	EDGAR2	Form 8-K - Current report
02/2/2024	15:21	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
01/2/2024	23:15	EDGAR2	Form EFFECT - Notice of Effectiveness
30/1/2024	07:13	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
30/1/2024	07:12	EDGAR2	Form 8-K - Current report
19/1/2024	15:16	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
19/1/2024	15:15	EDGAR2	Form 8-K - Current report
16/1/2024	07:45	EDGAR2	Form 8-K - Current report
20/12/2023	16:12	EDGAR2	Form PRE 14A - Other preliminary proxy statements
15/12/2023	16:02	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
05/12/2023	08:07	EDGAR2	Form 8-K - Current report
27/11/2023	07:38	EDGAR2	Form 8-K - Current report
24/11/2023	15:04	EDGAR2	Form 8-K - Current report
15/11/2023	07:07	EDGAR2	Form 8-K - Current report
01/11/2023	07:45	EDGAR2	Form 8-K - Current report
13/10/2023	15:40	EDGAR2	Form S-3 - Registration statement under Securities Act of..
25/8/2023	15:42	EDGAR2	Form 8-K - Current report
23/8/2023	08:07	EDGAR2	Form 8-K - Current report
14/8/2023	15:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
14/8/2023	07:08	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/2023	07:06	EDGAR2	Form 8-K - Current report
07/7/2023	15:03	EDGAR2	Form 8-K - Current report
06/7/2023	15:28	EDGAR2	Form 8-K/A - Current report: [Amend]